Cargando…
Multimeric ACE2-IgM fusions as broadly active antivirals that potently neutralize SARS-CoV-2 variants
Coronavirus infections are a world-wide threat to human health. A promising strategy to develop a broadly active antiviral is the use of fusion proteins consisting of an antibody IgG Fc region and a human ACE2 domain to which the viral spike proteins bind. Here we create antiviral fusion proteins ba...
Autores principales: | Svilenov, Hristo L., Bester, Romina, Sacherl, Julia, Absmeier, Ramona, Peters, Carsten, Protzer, Ulrike, Brockmeyer, Carsten, Buchner, Johannes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653429/ https://www.ncbi.nlm.nih.gov/pubmed/36371561 http://dx.doi.org/10.1038/s42003-022-04193-z |
Ejemplares similares
-
Mechanistic principles of an ultra-long bovine CDR reveal strategies for antibody design
por: Svilenov, Hristo L., et al.
Publicado: (2021) -
Picomolar inhibition of SARS-CoV-2 variants of concern by an engineered ACE2-IgG4-Fc fusion protein
por: Svilenov, Hristo L., et al.
Publicado: (2021) -
Extrinsic stabilization of antiviral ACE2-Fc fusion proteins targeting SARS-CoV-2
por: Svilenov, Hristo L., et al.
Publicado: (2023) -
Multimeric Anti-DR5 IgM Agonist Antibody IGM-8444 Is a Potent Inducer of Cancer Cell Apoptosis and Synergizes with Chemotherapy and BCL-2 Inhibitor ABT-199
por: Wang, Beatrice T., et al.
Publicado: (2021) -
ACE2-targeting monoclonal antibody as potent and broad-spectrum coronavirus blocker
por: Chen, Yuning, et al.
Publicado: (2021)